Thomas Castles

Fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta) is a single-inhaler triple therapy for the long-term, maintenance treatment of patients with chronic obstructive pulmonary disease.

Tymlos, an injection that treats postmenopausal women with osteoporosis, may incrase the risk of osteosarcoma.

Cholesterol-lowering drug approved in once-monthly 300 mg dosing option.